1. Pennington JAT, Young BE: Total diet study nutritional elements, 1982-1989. J Am Diet Assoc 91:179, 1991.
2. Dunn JT: Sources of dietary iodine in industrialized countries. In: Iodine Deficiency in Europe. A Continuing Concern. Eds: Delange F, Dunn JT, Glinoer D. Plenum Press, New York, 1993, pp 17-21.
3. Soldin OP, Soldin SJ, Pezzulo JC: Urinary iodide percentile ranges in the United States. Clinica Chimica Acta 328:185-190, 2003.
4. Dunn JT: Editorial: guarding our nation's thyroid health. J Clin Endocrinol Metab 87:486-488, 2002.
5. Hollowell JG, Staehling NW, Hannon WH, Flanders DW, Gunter EW, Maberly GF, Braverman LE, Pino S, Miller DT, Garbe PL, DeLozier DM, Jackson RJ: Iodine nutrition in the United States. Trends and public health implications: iodine excretion data from National Health and Nutritional Examination Surveys I and III (1971-1974 and 1988-1994). J Clin Endocrinol Metab 83:3401-3408, 1998.
6. Dunn JT: Editorial: What's happening to our iodine? J Clin Endocrinol Metab 83:3398-3400, 1998.
7. Pennington JAT, Schoen SA, Salmon GD, et al: Composition of core foods of the U.S. food supply, 1982-1991. J Food Comp Anal 8:171-217, 1995.
8. Fischer PWF, Giroux, A: Iodine content of a representative Canadian diet. J Can Diet Assoc 48:24-27, 1987.
9. Fischer PWF, Giroux A: Urinary iodine excretion by a selected sample of healthy Canadian adults. J Can Diet Assoc 51:337-340, 1990.
10. Takamura N, Hamada A, Yamaguchi N, Matsushita N, Tarasiuk I, Ohashi T, Aoyagi K, Mine M, Yamashita S: Urinary iodide kinetics after oral loading of potassium iodide. Endocrine Journal 50:589-593, 2003.
11. Vitti P, Delange F, Pinchera A, Zimmermann M, Dunn JT: Europe is iodine deficient (letter). Lancet 361:1126, 2003.
12. International Council for Control of Iodine Deficiency Disorders. Current Iodine Deficiency Disorders Status Database. http://www.iccidd.org, 2002.
13. Wynn JO: Components of the serum protein-bound iodine following administration of I131-labeled hog thyroglobulin. J Clin Endocrinol Metab 21:1572, 1961.
14. DeGroot LJ: Kinetic analysis of iodine metabolism. J Clin Endocrinol Metab 26:149, 1966.
15. McConahey WM, Keating FR, Power MH: An estimation of the renal and extrarenal clearance of radioiodine in man. J Clin Invest 30:778, 1951.
16. Bricker NS, Hlad CJ Jr: Observations on the mechanism of the renal clearance of I131. J Clin Invest 34:1057, 1955.
17. Perry WF, Hughes JFS: The urinary excretion and thyroid uptake of iodine in renal disease. J Clin Invest 31:457, 1952.
18. Berson SA, Yalow RS, Sorrentino J, Roswit B: The determination of thyroidal and renal plasma I131 clearance rates as a routine diagnostic test of thyroid dysfunction. J Clin Invest 31:141, 1952.
19. Weaver JC, Kamm ML, Dobson RL: Excretion of radioiodine in human milk. J Amer Med Assn 173:872, 1960.
20. Delange F: Requirements of iodine in humans. In: Iodine Deficiency in Europe. A Continuing Concern. Eds: Delange F, Dunn JT, Glinoer D. Plenum Press, New York, 1993, pp 5-13.
21. Pitt-Rivers R, Trotter WR: The site of accumulation of iodide in the thyroid of rats treated with thiouracil. Lancet 2:918, 1953.
22. Andos G, Wollman SH: Autoradiographic localization of radioiodide in the thyroid gland of the mouse. Am J Physiol 213:198, 1967.
23. Pochin EE: Investigation of thyroid function and disease with radioactive iodine. Lancet 2:41-84, 1950.
24. Berson SA, Yalow RS: The iodide trapping and binding functions of the thyroid. J Clin Invest 34:186, 1955.
25. Wolff J: Transport of iodide and other anions in the thyroid gland. Physiol Rev 44:45, 1964.
26. Wolff J: Thyroidal iodide transport. I. Cardiac glycosides and the role of potassium. Biochim Biophys Acta 38:316, 1960.
27. Brunbert JA, Halmi NS: The role of ouabain-sensitive adenosine triphosphatase in the stimulating effect of thyrotropin on the iodide pump of the rat thyroid. Endocrinology 79:801, 1966.
28. Dai G, Levy O, Carrasco N: Cloning and characterization of the thyroid iodide transporter. Nature 379:458-460, 1996.
29. Levy O, Dai G, Riedel C, Ginter CS, Paul EM, Lebowitz AN, Carrasco N: Characterization of the thyroid Na+/I- symporter with an anti-COOH terminus antibody. Proc Natl Acad Sci USA 94:5568-73, 1997.
30. Paire A, Bernier-Valentin F, Selmi-Ruby S, Rousset B: Characterization of the rat thyroid iodide transporter using anti-peptide antibodies. Relationship between its expression and activity. J Biol Chem 272:18245-9, 1997.
31. Levy O, de la Vieja A, Ginter CS, Riedel C, Dai G, Carrasco N: N-linked glycosylation of the thyroid Na+/I- symporter (NIS). Implications for its secondary structure model. J Biol Chem 273:22657-63, 1998.
32. Eskandari S, Loo DD, Dai G, Levy O, Wright EM, Carrasco N: Thyroid Na+/I- symporter. Mechanism, stoichiometry, and specificity. J Biol Chem 272:27230-8, 1997.
33. Smanik PA, Ryu K-Y, Theil KS, et al: Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter. Endocrinology 138:3555-3558, 1997.
34. Smanik PA, Liu Q, Furminger TL, et al: Cloning of the human sodium iodide symporter. Biochem Biophys Res Comm 226:339-345, 1996.
35. Perron B, Rodriguez AM, Leblanc G, Pourcher T: Cloning of the mouse sodium iodide symporter and its expression in the mammary gland and other tissues. J Endocrinol 170:185-196, 2001.
36. Selmi-Ruby S, Watrin C, Trouttet-Masson S, Bernier-Valentin F, Flachon V, Munari-Silem Y, Rousset B: The porcine sodium/iodide symporter gene exhibits an uncommon expression pattern related to the use of alternative splice sites not present in the human or murine species. Endocrinology 144:1074-1085, 2003.
37. Kogai T, Endo T, Saito T, et al: Regulation by thyroid-stimulating hormone of sodium/iodide symporter gene expression and protein levels in FRTL-5 cells. Endocrinology 138:2227-2232, 1997.
38. Ohno M, Zannini M, Levy O, Carrasco N, di Lauro R: The paired-domain transcription factor Pax8 binds to the upstream enhancer of the rat sodium/iodide symporter gene and participates in both thyroid-specific and cyclic-AMP-dependent transcription. Mol Cell Biol 19:2051-2060, 1999.
39. Taki K, Kogai T, Kanamoto Y, Hershman JM, Brent GA. A thyroid-specific far-upstream enhancer in the human sodium/iodide symporter gene requires Pax-8 binding and cyclic adenosine 3’,5’-monophosphate response element-like sequence binding proteins for full activity and is differentially regulated in normal and thyroid cancer cells. Mol Endocrinol 16:2266-2282, 2002.
40. Lin X, Ryu KY, Jhiang SM: Cloning of the 5’-flanking region of mouse sodium/iodide symporter and identification of a thyroid-specific and TSH-responsive enhancer. Thyroid 14:19-27, 2004.
41. Riedel C, Levy O, Carrasco N: Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin. J Biol Chem 276:21458-63, 2001.
42. Marians RC, Ng L, Blair HC, Unger P, Graves PN, Davies TF: Defining thyrotropin-dependent and –independent steps of thyroid hormone synthesis by using thyrotropin receptor-null mice. Proc Natl Acad Sci USA 99:15776-81, 2002.
43. Postiglione MP, Parlato R, Rodriguez-Mallon A, Rosica A, Mithbaokar P, Maresca M, Marians RC, Davies TF, Zannini MS, de Felice M, di Lauro R: Role of the thyroid-stimulating hormone receptor signaling in development and differentiation of the thyroid gland. Proc Natl Acad Sci USA 99:15642-7, 2002.
44. Uyttersprot N, Pelgrims N, Carrasco N, et al: Moderate doses of iodide in vivo inhibit cell proliferation and the expression of thyroperoxidase and Na+/I- symporter mRNAs in dog thyroid. Mol Cell Endocrinol 131:195-203, 1997.
45. Eng PH, Cardona GR, Fang SL, Previti M, Alex S, Carrasco N, Chin WW, Braverman LE: Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology 140:3404-3410, 1999.
46. Pekary AE, Hershman JM: Tumor necrosis factor, ceramide, transforming growth factor-beta1, and aging reduce Na+/I- symporter messenger ribonucleic acid levels in FRTL-5 cells. Endocrinology 139:703-712, 1998.
47. Costamagna E, Garcia B, Santisteban P: The functional interaction between the paired domain transcription factor Pax8 and Smad3 is involved in transforming growth factor-beta repression of the sodium/iodide symporter gene. J Biol Chem 279:3439-3946, 2004.
48. Riedel C, Dohan O, de la Vieja A, Ginter CS, Carrasco N: Journey of the iodide transporter NIS: from its molecular identification to its clinical role in cancer. Trends Biochem Sci 26:490-496, 2001.
49. Dohan O, de la Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS, Carrasco N: The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 24:48-77, 2003.
50. Fujiwara H. Tatsumi K, Miki K, et al: Congenital hypothyroidism caused by a mutation in the Na+/I- symporter (letter). Nature Genetics 16:124-125, 1997.
51. Matsuda A, Kosugi S: A homozygous missense mutation of the sodium/iodide symporter gene causing iodide transport defect. J Clin Endocrinol Metab 82:3966-3971, 1997.
52. Pohlenz J, Rosenthal IM, Weiss RE: Congenital hypothyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic 3' splice site. J Clin Invest 101:1028-1035, 1998.
53. Fujiwara H, Tatsumi K-I, Miki K, Harada T, Okada S, Nose O et al.: Recurrent T354P mutation of the Na+/I- symporter in patients with iodide transport defect. J Clin Endocrinol Metab 83:2940-2943, 1998.
54. Kosugi S, Inoue S, Matsuda A, Jhiang SM: Novel, missense and loss-of-function mutations in the sodium/iodide symporter gene causing iodide transport defect in three Japanese patients. J Clin Endocrinol Metab 83:3373-3376, 1998.
55. Kosugi S, Sato Y, Matsuda A, Ohyama Y, Fujieda K, Hiroaki I et al.: High prevalence of T354P sodium/iodide symporter gene mutation in Japanese patients with iodide transport defect who have heterogeneous clinical pictures. J Clin Endocrinol Metab 83:4123-4129, 1998.
56. Kosugi S, Bhayana S, Dean HJ: A novel mutation in the sodium/iodide symporter gene in the largest family with iodide transport defect. J Clin Endocrinol Metab 84:3248-3253, 1999.
57. Pohlenz J, Duprez L, Weiss R, Vassart G, Refetoff S, Costagliola S: Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters. J Clin Endocrinol Metab 85:2366-2369, 2000.
58. Levy O, Ginter CS, de la Vieja A, Levy D, Carrasco N : Identification of a structural requirement for thyroid Na+/I- symporter (NIS) function from analysis of a mutation that causes human congenital hypothyroidism. FEBS Lett 429:36-40, 1998.
59. Saito T, Endo T, Kawaguchi A, et al: Increased expression of the Na+/I- symporter in cultured human thyroid cells exposed to thyrotropin and in Graves' thyroid tissue. J Clin Endocrinol Metab 82:3331-3336, 1997.
60. Lazar V, Bidart JM, Caillou B, Mahe C, Lacroix L, Filetti S, Schlumberger M: Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab 84:3228-3234, 1999.
61. Trouttet-Masson S, Selmi-Ruby S, Bernier-Valentin F, Porra V, Berger-Dutrieux N, Decaussin M, Peix J-L, Perrin A, Bournaud C, Orgiazzi J, Borson-Chazot F, Franc B, Rousset B: Evidence for transcriptional and post-transcriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors. Am J Pathol, 2004 (in press).
62. Jhiang SM, Cho J-Y, Ryu KY, et al: An immunohistochemical study of Na+/I- symporter in human thyroid tissues and salivary gland tissues. Endocrinology 139:4416-4419, 1998.
63. Tazebay UH, Wapnir IL, Levy O, et al: The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med 6:871-878, 2000.
64. Cho JY, Leveille R, Kao R, Rousset B, Parlow AF, Burak WE Jr, Mazzaferri EL, Jhiang SM: Hormonal regulation of radioiodide uptake activity and Na+/I- symporter expression in mammary glands. J Clin Endocrinol Metab 85:2936-2943, 2000.
65. Royaux IE, Suzuki K, Mori A, et al: Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. Endocrinology 141:839-845, 2000.
66. Yoshida A, Taniguchi S, Hisatome I, Royaux IE, Green ED, Kohn LD, Suzuki K: Pendrin is an iodide-specific apical porter responsible for iodide efflux from thyroid cells. J Clin Endocrinol Metab 87:3356-3361, 2002.
67. Rodriguez AM, Perron B, Lacroix L, Caillou B, Leblanc G, Schlumberger M, Bidart JM, Pourcher T: Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes. J Clin Endocrinol Metab 87:3500-3503, 2002.
68. Everett LA, Glaser B, Beck JC, Idol JR, Buchs A, Heyman M, Adawi F, Hazani E, Nassir E, Baxevanis AD, Sheffield VC, Green ED: Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 17:411-422, 1997.
69. Porra V, Bernier-Valentin F, Trouttet-Masson S, Berger-Dutrieux N, Peix JL, Perrin A, Selmi-Ruby S, Rousset B: Characterization and semiquantitative analyses of pendrin expressed in normal and tumoral human thyroid tissues. J Clin Endocrinol Metab 87:1700-1707, 2002.
70. Bidart JM, Mian C, Lazar V, Russo D, Filetti S, Caillou B, Schlumberger M: Expression of pendrin and the Pendred syndrome (PDS) gene in human thyroid tissues. J Clin Endocrinol Metab 85:2028-2033, 2000.
71. Scott DA, Wang R, Kreman TM, Sheffield VC, Karnishki LP: The Pendred syndrome gene encodes a chloride-iodide transport protein. Nat Genet 21:440-443, 1999.
72. Soleimani M, Greeley T, Petrovic S, Wang Z, Amlal H, Kopp P, Burnham CE: Pendrin: an apical Cl(-)/OH(-)/HCO(3)(-) exchanger in the kidney cortex. Am J Physiol Renal Physiol 280:356-364, 2001.
73. Gillam MP, Sidhaye AR, Lee EJ, Rutishauser J, Waeber Stephan C, Kopp P: Functional characterization of pendrin in a polarized cell system: evidence for pendrin-mediated apical iodide efflux. J Biol Chem, 2004 (in press).
74. Taylor JP, Metcalfe RA, Watson PF, Weetman AP, Trembath RC: Mutations of the PDS gene, encoding pendrin, are associated with protein mislocalization and loss of iodide efflux: implications for thyroid dysfunction in Pendred syndrome. J Clin Endocrinol Metab 87:1778-1784, 2002.
75. Everett LA, Belyantseva IA, Noben-Trauth K, Cantos R, Chen A, Thakkar SI, Hoogstraten-Miller SL, Kachar B, Wu DK, Green ED: Targeted disruption of mouse PDS provides insight about the inner-ear defects encountered in Pendred syndrome. Hum Mol Genet 10:153-161, 2001.
76. van Sande J, Massart C, Beauwens R, Schoutens A, Costagliola S, Dumont JE, Wolff J: Anion selectivity by the sodium iodide symporter. Endocrinology 144:247-252, 2003.
77. DeGroot LJ, Davis AM: The early stage of thyroid hormone formation. Studies on rat thyroids in vivo. Endocrinology 69:695, 1961.
78. Hildebrandt JD, Scranton JR, Halmi NS: Intrathyroidally generated iodide: Its measurement and origins. Endocrinology 105:618, 1979.
79. Rosenberg IN, Athans JC, Ahr CS, Behar A: Thyrotropin-induced release of iodide from the thyroid. Endocrinology 69:438, 1961.
80. Ingbar SH: Simultaneous measurement of the iodide-concentrating and protein-binding capacities of the normal and hyperfunctioning human thyroid gland. J Clin Endocrinol Metab 15:238, 1955.
81. Thrall KD, Bull RJ, Sauer RL: Distribution of iodine into blood components of the Sprague-Dawley rat differs with the chemical form administered. J Toxicol Environ Health 37:443-449, 1992.
82. Eskin BA, Grotkowski CE, Connolly CP, Ghent WR: Different tissue responses for iodine and iodide in rat thyroid and mammary glands. Biol Trace Element Res 49:9-19, 1995.
83. Ohtaki S, Nakagawa H, Nakamura M, Yamazaki I: Reactions of purified hog thyroid peroxidase with H2O2, tyrosine, and methylmercaptoimidazole (Goitrogen) in comparison with bovine lactoperoxidase. J Biol Chem 257:761, 1982.
84. Ohtaki S, Nakagawa H, Nakamura M, Yamazaki I: One- and two-electron oxidations of tyrosine, monoiodotyrosine, and diiodotyrosine catalyzed by hog thyroid peroxidase. J Biol Chem 257:13398, 1982.
85. Krinsky MM, Alexander NM: Thyroid peroxidase. Nature of the heme binding to apoperoxidase. J Biol Chem 246:4755, 1971.
86. Niepomniszcze H, DeGroot LJ, Hagen GA: Abnormal thyroid peroxidase causing iodide organification defect. J Clin Endocrinol Metab 34:607, 1972.
87. Portmann L, Hamada N, Heinrich G, DeGroot LJ: Antithyroid peroxidase antibody in patients with autoimmune thyroid disease: possible identity with antimicrosomal antibody. J Clin Endocrinol Metab 61:1001-1003, 1985.
88. Czarnocka B, Ruf J, Ferrand M, Carayon P, Lissitzky S: Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett 190:147-152, 1985.
89. Kotani T, Umeki K, Matsunaga S, Kato E, Ohtaki S: Detection of autoantibodies to thyroid peroxidase in autoimmune thyroid diseases by micro-ELISA and immunoblotting. J Clin Endocrinol Metab 62:928-933, 1986.
90. Ruf J, Czarnocka B, de Micco C, Dutoit C, Ferrand M, Carayon P: Thyroid peroxidase is the organ-specific ‘microsomal’ autoantigen involved in thyroid autoimmunity. Acta Endocrinol Suppl (Copenh) 281:49-56, 1987.
91. Hamada N, Portmann L, DeGroot LJ: Characterization and isolation of thyroid microsomal antigen. J Clin Invest 79:819-825, 1987.
92. Kimura S, Kotani T, McBride OW, et al: Human thyroid peroxidase: complete cDNA and protein sequence, chromosome mapping, and identification of two alternately spliced mRNAs. Proc Natl Acad Sci USA 84:5555-5559, 1987.
93. Seto P, Hirayu H, Magnusson RP, Gestautas J, Portmann L, DeGroot LJ, Rapoport B: Isolation of a complementary DNA clone for thyroid microsomal antigen. Homology with the gene for thyroid peroxidase. J Clin Invest 80:1205-1208, 1987.
94. Libert F, Ruel J, Ludage M, Swillens S, Alexander N, Vassart G, Dinsart C: Thyroperoxidase, an auto-antigen with a mosaic structure made of nuclear and mitochondrial gene modules. EMBO J 6:4193-4196, 1987.
95. Magnusson RP, Gestautas J, Taurog A, Rapoport B: Molecular cloning of the structural gene for porcine thyroid peroxidase. J Biol Chem 262:13885-13888, 1987.
96. Derwahl M, Seto P, Rapoport B: Complete nucleotide sequence of the cDNA for thyroid peroxidase in FRTL-5 rat thyroid cells. Nucleic Acids Res 17:8380, 1989.
97. Kotani T, Umeki K, Yamamoto I, et al: Nucleotide sequence of the cDNA encoding mouse thyroid peroxidase. Gene 123:289, 1993.
98. Niccoli P, Fayadat L, Panneels V, et al: Human thyroperoxidase in its alternatively spliced form (TPO2) is enzymatically inactive and exhibits changes in intracellular processing and trafficking. J Biol Chem 272:29487-29492, 1997.
99. Fayadat L, Siffroi-Fernandez S, Lanet J, Franc JL: Degradation of human thyroperoxidase in the endoplasmic reticulum involves two different pathways depending on the folding state of the protein. J Biol Chem 275:15948-15954, 2000.
100. Ferrand M, Le Fourn V, Franc JL: Increasing diversity of human thyroperoxidase generated by alternative splicing, characterized by molecular cloning of new transcripts with single- and multispliced mRNAs. J Biol Chem 278:3793-3800, 2003.
101. Rawitch AB, Pollock G, Yang SX, Taurog A: The location and nature of the N-linked oligosaccharide units in porcine thyroid peroxidase: studies on the tryptic glycopeptides. In: Thyroperoxidase and Thyroid Autoimmunity. Eds: Carayon P, Ruf J. John Libbey Eurotext, London, 1990, pp 69-76.
102. de Vijlder JJM, Dinsart C, Libert F, Geurts van Kessel A, Bikker H, Bolhuis PA, Vassart G: Regional localization of the gene for thyroid peroxidase to human chromosome 2pter p12. Cytogenet Cell Genet 47:170-172, 1988.
103. Damante G, di Lauro R: Thyroid-specific gene expression. Biochim Biophys Acta 1218:255-266, 1994.
104. Kambe F, Seo H: Thyroid-specific transcription factors. Endocrine J 44:775-784, 1997.
105. Ericson LE, Johanson V, Molne J, Nilsson M, Ofverholm T: Intracellular transport and cell surface expression of thyroperoxidase. In: Thyroperoxidase and Thyroid Autoimmunity. Eds: Carayon P, Ruf J. John Libbey Eurotext, London, 1990, pp 107-116.
106. Yokoyama N, Taurog A: Porcine thyroid peroxidase: relationship between the native enzyme and an active, highly purified tryptic fragment. Mol Endocrinol 2:838-844, 1988.
107. Fayadat L, Niccoli-Sire P, Lanet J, Franc JL: Human thyroperoxidase is largely retained and rapidly degraded in the endoplasmic reticulum. Its N-glycans are required for folding and intracellular trafficking. Endocrinology 139:4277-4285, 1998.
108. Alquier C, Ruf J, Athouel-Haon AM, Carayon P: Immunocytochemical study of localization and traffic of thyroid peroxidase/microsomal antigen. Autoimmunity 3:113-123, 1989.
109. Penel C, Gruffat D, Alquier C, et al: Thyrotropin chronically regulates the pool of thyroperoxidase and its intracellular distribution: a quantitative confocal microscopic study. J Cell Physiol 174:160-169, 1998.
110. Dupuy C, Virion A, Kaniewski J, Deme D, Pommier J: Thyroid NADPH-dependent H2O2 generating system: mechanism of H2O2 formation and regulation by Ca2+. In: Thyroperoxidase and Thyroid Autoimmunity. Eds: Carayon P, Ruf J. John Libbey Eurotext, London, 1990, pp 95-102.
111. Bjorkman U, Ekholm R: Hydrogen peroxide generation and its regulation in FRTL-5 and porcine thyroid cells. Endocrinology 130:393-399, 1992.
112. Carvalho DP, Dupuy C, Gorin Y, et al: The Ca2+- and reduced nicotinamide adenine dinucleotide phosphate-dependent hydrogen peroxide generating system is induced by thyrotropin in porcine thyroid cells. Endocrinology 137:1007-1012, 1996.
113. de Deken X, Wang D, Many MC, et al: Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem 275:23227-23233, 2000.
114. Dupuy C, Ohayon R, Valent A, Noel-Hudson MS, Deme D, Virion A: Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. Cloning of the porcine and human cDNAs. J Biol Chem 274:37265-37269, 1999.
115. Caillou B, Dupuy C, Lacroix L, et al: Expression of reduced nicotinamide adenine dinucleotide phosphate oxidase (ThoX, LNOX, Duox) genes and proteins in human thyroid tissues. J Clin Endocrinol Metab 86:3351-3358, 2001.
116. de Deken X, Wang D, Dumont JE, Miot F: Characterization of ThOX proteins as components of the thyroid H2O2-generating system. Exp Cell Res 273:187-196, 2002.
117. Nakamura Y, Ohtaki S, Makino R, et al: Superoxide anion is the initial product in the hydrogen peroxide formation catalyzed by NADPH oxidase in porcine thyroid plasma membrane. J Biol Chem 264:4759-4761, 1989.
118. Dupuy C, Virion A, Ohayon R, et al: Mechanism of hydrogen peroxide formation catalyzed by NADPH oxidase in thyroid plasma membrane. J Biol Chem 266:3739-3743, 1991.
119. Morand S, Chaaraoui M, Kaniewski J, Deme D, Ohayon R, Noel-Hudson MS, Virion A, Dupuy C: Effect of iodide on nicotinamide adenine dinucleotide phosphate oxidase activity and Duox2 protein expression in isolated porcine thyroid follicles. Endocrinology 144:1214-1248, 2003.
120. Corvilain B, van Sande J, Laurent E, Dumont JE: The H2O2-generating system modulates protein iodination and the activity of the pentose phosphate pathway in dog thyroid. Endocrinology 128:779-785, 1991.
121. Raspe E, Dumont JE: Tonic modulation of dog thyrocyte H2O2 generation and I- uptake by thyrotropin through the cyclic adenosine 3',5'-monophosphate cascade. Endocrinology 136:965-973, 1995.
122. Kimura T, Okajima F, Sho K, et al: Thyrotropin-induced hydrogen peroxide production in FRTL-5 thyroid cells is mediated not by adenosine 3',5'monophosphate, but by Ca2+ signaling followed by phospholipase-A2 activation and potentiated by an adenosine derivative. Endocrinology 136:116-123, 1995.
123. Corvilain B, van Sande J, Dumont JE: Inhibition by iodide of iodide binding to proteins: the “Wolff-Chaikoff” effect is caused by inhibition of H2O2 generation. Biochem Biophys Res Commun 154:1287-1292, 1988.
124. Corvilain B, Collyn L, van Sande J, Dumont JE: Stimulation by iodide of H2O2 generation in thyroid slices from several species. Am J Physiol Endocrinol Metab 278:692-699, 2000.
125. Corvilain B, Laurent E, Lecomte M, van Sande J, Dumont JE: Role of the cyclic adenosine 3’,5’-monophosphate and the phosphatidylinositol-Ca2+ cascades in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices. J Clin Endocrinol Metab 79:152-159, 1994.
126. Dunn JT, Dunn AD: Thyroglobulin: chemistry, biosynthesis, and proteolysis. In: The Thyroid, 8th edition. Eds: Braverman LE, Utiger R. Lippincott Williams & Wilkins, Philadelphia, 2000, pp 91-104.
127. Mendive FM, Rivolta CM, Moya CM, Vassart G, Targovnik HM: Genomic organization of the human thyroglobulin gene: the complete intron-exon structure. Eur J Endocrinol 145:485-496, 2001
128. Malthiery Y, Lissitzky S: Primary structure of human thyroglobulin deduced from the sequence of its 8448-base complementary DNA. Eur J Biochem 165:491-498, 1987.
129. van de Graaf SAR, Pauws E, de Vijlder JJM, Ris-Stalpers C: The revised 8307 base pair coding sequence of human thyroglobulin transiently expressed in eukaryotic cells. Eur J Endocrinol 136:508-515, 1997.
130. Mercken L, Simons M-J, Swillens S, et al: Primary structure of bovine thyroglobulin deduced from the sequence of its 8,431-base complementary DNA. Nature 316:647-651, 1985.
131. di Lauro R, Avvedimento EV, Cerillo R, et al. Structure and function of the rat thyroglobulin gene. In: Thyroglobulin - The Prothyroid Hormone. Progress in Endocrine Research and Therapy, vol. 2. Eds: Eggo MC, Burrow GN. Raven Press, New York, 1985, pp 77-86.
132. Kim PS, Hossain SA, Park Y-N, et al: A single amino acid change in the acetylcholinesterase-like domain of thyroglobulin causes congenital goiter with hypothyroidism in the cog/cog mouse: a model of human endoplasmic reticulum storage diseases. Proc Natl Acad Sci USA 95:9909-9913, 1998.
133. van de Graaf SAR, Ris-Stalpers C, Pauws E, et al: Up to date with human thyroglobulin. J Endocr 170:307-321, 2001.
134. Lenarcie B, Krishnan G, Borukhovich R, Ruck B, Turk V, Moczydlowski E. Saxiphilin, a saxitoxin-binding protein with two thyroglobulin type1 domains, is an inhibitor of papain-like cysteine. J Biol Chem 275:15572-15577, 2000
135. Molina F, Pau B, Granier C: The type-1 repeats of thyroglobulin regulate thyroglobulin degradation and T3, T4 release in thyrocytes. FEBS Lett 391:229-231, 1996.
136. Swillens S, Ludgate M, Mercken L. Dumont JE, Vassart G: Analysis of sequence and structure homologies between thyroglobulin and acetylcholinesterace: possible functional and clinical significance. Biochem Biophys Res Commun 137:142, 1986.
137. Park YN, Arvan P:The acetylcholinesterase-homology region is essential for normal conformational maturation and secretion of thyroglobulin. J Biol Chem, in press, 2004.
138. Klein M, Gestmann I, Berndorfer U, Schmitz A, Herzog V: The thioredoxin boxes of thyroglobulin: possible implications for intermolecular disulfide bond formation in the follicle lumen. Biol Chem 381:593-601, 2000.
139. Kambe F, Nomura Y, Okamoto T, Seo H: Redox regulation of thyroid-transcription factors, Pax-8 and TTF-1, is involved in their increased DNA-binding activities by thyrotropin in rat thyroid FRTL-5 cells. Mol Endocrinol 10:801-812, 1996.
140. Tell G, Scaloni A, Pellizzari L, Formisano S, Pucillo C, Damante G: Redox potential controls the structure and DNA binding activity of the paired domain. J Biol Chem 273:25062-25072, 1998.
141. Tell G, Pines A, Paron I, D’Elia A, Bisca A, Kelley MR, Manzini G, Damante G: Redox effector factor-1 regulates the activity of thyroid transcription factor 1 by controlling the redox state of the N transcriptional activation domain. J Biol Chem 277:14564-14574, 2002.
142. Cao X, Kambe F, Ohmori S, Seo H: Oxidoreductive modification of the two cysteine residues in paired domain by Ref-1 regulates DNA-binding activity of Pax-8. Biochem Biophys Res Commun 297:288-293, 2002
143. Kim PS, Arvan P: Folding and assembly of newly synthesized thyroglobulin occurs in a pre-Golgi compartment. J Biol Chem 266:12412-12418, 1991.
144. Kim PS, Bole D, Arvan P: Transient aggregation of nascent thyroglobulin in the endoplasmic reticulum: relationship to the molecular chaperone, BiP. J Cell Biol 118:541-549, 1992.
145. Kim PS, Arvan P: Calnexin and BiP act as sequential molecular chaperones during thyroglobulin folding in the endoplasmic reticulum. J Cell Biol 128:29-38, 1995.
146. Muresan Z, Arvan P: Thyroglobulin transport along the secretory pathway. J Biol Chem 272:26095-26102, 1997.
147. Muresan Z, Arvan P: Enhanced binding to the molecular chaperone BiP slows thyroglobulin export from the endoplasmic reticulum. Mol Endocrinol 12:458-467, 1998.
148. Martin-Belmonte F, Alonso MA, Zhang X, Arvan P:Thyroglobulin is selected as lumenal protein cargo for apical transport via detergent-resistant membranes in epithelial cells. J Biol Chem.275:41074-41081, 2000.
149. Arima T, Spiro MJ, Spiro RG: Studies on the carbohydrate units of thyroglobulin. J Biol Chem 247:1825, 1972.
150. Yang S-X, Pollock HG, Rawitch AB: Glycosylation in human thyroglobulin: location of the N-linked oligosaccharide units and comparison with bovine thyroglobulin. Arch Biochem Biophys 327:61-70, 1996.
151. Spiro MJ: Presence of a glucuronic acid-containing carbohydrate unit in human thyroglobulin. J Biol Chem 252:5424, 1977.
152. Mayerhofer A, Amador AG, Beamer WG, Bartke A: Ultrastructural aspects of the goiter in cog/cog mice. J Heredity 79:200-203, 1988.
153. Kim PS, Kwon O-Y, Arvan P: An endoplasmic reticulum storage disease causing congenital goiter with hypothyroidism. J Cell Biol 133:517-527, 1996.
154. Kim PS, Arvan P: Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones. Endocr Rev 19:173-202, 1998.
155. Ohyama Y, Hosoya T, Kameya T, et al: Congenital euthyroid goitre with impaired thyroglobulin transport. Clin Endocrinol 41:129-135, 1994.
156. Targovnik HM, Vono J, Billerbeck AEC, et al: A 138-nucleotide deletion in the thyroglobulin ribonucleic acid messenger in a congenital goiter with defective thyroglobulin synthesis. J Clin Endocrinol Metab 80:3356-3360, 1995.
157. Medeiros-Neto G, Kim PS, Yoo SE, et al: Congenital hypothyroid goiter with deficient thyroglobulin. Identification of an endoplasmic reticulum storage disease with induction of molecular chaperones. J Clin Invest 98:2838-2844, 1996.
158. Cauvi D, Nlend MC, Venot N, Chabaud O: Sulfate transport in porcine thyroid cells. Effects of thyroglobulin and iodide. Am J Physiol Endocrinol Metab 281:E440-448, 2001
159. Consiglio E, Acquaviva AM, Formisano S, et al: Characterization of phosphate residues on thyroglobulin. J Biol Chem 262:10304, 1987.
160. Spiro MJ, Gorski KM: Studies on the posttranslational migration and processing of thyroglobulin: use of inhabitors and evaluation of the role of phosphorylation. Endocrinology 119:1146, 1986.
161. Yamamoto K, Tsuji T, Tarutani O, Osawa T: Structural changes of carbohydrate chains of human thyroglobulin accompanying malignant transformations of thyroid glands. Eur J Biochem 143:133, 1984.
162. Alvino CG, Acquaviva AM, Memoli Catanzano AM, Tassi V: Evidence that thyroglobulin has an associated protein kinase activity correlated with the presence of an adenosine triphosphate binding site. Endocrinology 136:3179-3185, 1995.
163. Taurog A: Hormone synthesis: thyroid iodine metabolism. In: The Thyroid, 8th edition. Eds: Braverman LE, Utiger RD. Lippincott Williams & Wilkins, Philadelphia, 2000, pp 61-85.
164. Ohtaki S, Nakagawa H, Kimura S, Yamazaki I: Analyses of catalytic intermediates of hog thyroid peroxidase during its iodinating reaction. J Biol Chem 256:805, 1981.
165. Cahmann HJ, Pommier J, Nunez J: Spatial requirement for coupling of iodotyrosine residues to form thyroid hormone. Proc Natl Acad Sci USA 74:.5333-5335, 1977
166. Deme D, Pommier J, Nunez J: Specificity of thyroid hormone synthesis. The role of thyroid peroxidase. Biochim Biophys Acta 540:73-82, 1978.
167. Virion A, Pommier J, Deme D, Nunez J:Kinetics of thyroglobulin iodination and thyroid hormone synthesis catalyzed by peroxidase:therole of H2O2. Eur J Biochem 117:103-109, 1981.
168. Virion A, Courtin F, Deme D, Michot JL, Kaniewski J, Pommier J: Spectral characteristics and catalytic properties of thyroid peroxidase-H2O2 compounds in the iodination and coupling reactions. Arch Biochem Biophys 242:41-47, 1985.
169. Lamas L, Taurog A, Salvatore G, Edelhoch H: The importance of thyroglobulin structure i thyroid peroxidase-catalyzed conversion of diiodotyrosine to thyroxine. J Biol Chem 249:2732-2737, 1974.
170. Johnson TB, Tewkesbury LB: The oxydation of 3,5-diiodotyrosine to thyroxine. Proc Natl Acad Sci USA 28:73-77, 1942.
171. Gavaret J-M, Nunez J, Cahnmann HJ: Formation of dehydroalanine residues during thyroid hormone synthesis in thyroglobulin. J Biol Chem 255:5281-5285, 1980.
172. Gavaret JM, Cahnmann HJ, Nunez J: Thyroid hormone synthesis in thyroglobulin; the mechanism of the coupling reaction. J Biol Chem 256:9167-9172, 1981.
173. Xiao S, Dorris ML, Rawitch AB, Taurog A: Selectivity in tyrosyl iodination sites in human thyroglobulin. Arch Biochem Biophys 334:284-294, 1996.
174. Roe MT, Anderson PC, Dunn AD, Dunn JT: The hormonogenic sites of turtle thyroglobulin and their homology with those of mammals. Endocrinology 124:1327-1332, 1989.
175. Kim PS, Dunn JT, Kaiser DL: Similar hormone-rich peptides from thyroglobulins of five vertebrate classes. Endocrinology 114:369-374, 1984.
176. Fassler CA, Dunn JT, Anderson PC, et al: Thyrotropin alters the utilization of thyroglobulin's hormonogenic sites. J Biol Chem 263:17366-17371, 1988.
177. Lamas L, Anderson PC, Fox JW, Dunn JT: Consensus sequences for early iodination and hormonogenesis in human thyroglobulin. J Biol Chem 264:13541-13545, 1989.
178. Marriq C, Lejeune P-J, Venot N, Vinet L: Hormone formation in the isolated fragment 1-171 of human thyroglobulin involves the couple tyrosine 5 and tyrosine 130. Mol Cell Endocrinol 81:155-165, 1991.
179. Xiao S, Pollock G, Taurog A, Rawitch AB: Characterization of hormonogenic sites in an N-terminal, cyanogen bromide fragment of human thyroglobulin. Arch Biochem Biophys 320:96-105, 1995.
180. den Hartog M, Sijmons CC, Bakker O, et al: Importance of the content and localization of tyrosine residues for thyroxine formation within the N-terminal part of human thyroglobulin. Eur J Endocrinol 132:611-617, 1995.
181. Dunn AD, Corsi CM, Myers HE, Dunn JT: Tyrosine 130 is an important outer ring donor for thyroxine formation in thyroglobulin. J Biol Chem 273:25223-25229, 1998.
182. Gentile F, Ferranti P, Mamone G, et al: Identification of hormonogenic tyrosines in fragment 1218-1591 of bovine thyroglobulin by mass spectrometry. J Biol Chem 272:639-646, 1997.
183. Duthoit C, Estienne V, Delom F, et al: Production of immunoreactive thyroglobulin C-terminal fragments during thyroid hormone synthesis. Endocrinology 141:2518-2525, 2000.
184. Dunn, JT, Kim PS, Dunn AD: Favored sites for thyroid hormone formation on the peptide chains of human thyroglobulin. J Biol Chem 257:88-94, 1982.
185. Dunn JT, Kim PS, Dunn AD, et al: The role of iodination in the formation of hormone-rich peptides from thyroglobulin. J Biol Chem 258:9093-9099, 1983.
186. Wolff J, Chaikoff IL: Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem 174:555-564, 1948.
187. deVijlder VVM, Veenboer GVM, Van Dijk JE. Thyroid albumin originates from blood. Endocrinology 131:578-584, 1992.
188. DeGroot LJ, Hall R, McDermott WV, Davis AM: Hashimoto's thyroiditis. A genetically conditioned disease. N Engl J Med 267:267, 1962.
189. DeGroot LJ, Stanbury JB: The syndrome of congenital goiter with butanol-insoluble serum iodine. Am J Med 27:586, 1959.
190. Stanbury JB, Janssen MA: Labeled iodoalbumin in the plasma in thyrotoxicosis after I125 and I131. J Clin Endocrinol Metab 23:1056, 1963.
191. Robbins J, Wolff J, Rall JE: Iodoproteins in normal and abnormal human thyroid tissue and in normal sheep thyroid. Endocrinology 64:37, 1959.
192. Gire V, Kostrouch Z, Bernier-Valentin F, Rabilloud R, Munari-Silem Y,Rousset B: Endocytosis of albumin and thyroglobulin at the basolateral membrane of thyrocytes organized in follicles. Endocrinology 137:522-532, 1996.
193. Boeynaems JM, Van Sande J, Dumont JE: Which lipids are involved in thyroid autoregulation: iodolactones or iodoaldehydes? Eur J Endocrinol 132:733-734, 1995.
194. Gartner R, Dugrillon A, Bechtner G: Iodolipids and thyroid function and growth. In: The Thyroid and Iodine. Eds: Nauman J, Glinoer D, Braverman LE, Hostalek U. Merck European Thyroid Symposium, Stuttgart, New York, 1996, pp 19-27.
195. Pereira A, ,, Dumont JE, Boeynaems J-M: Identification of a major iodolipid from the horse thyroid gland as 2-iodohexadecanal. J Biol Chem 265:17018-17025, 1990.
196. Paneels V, Macours P, Van den Bergen H, Braekman JC, Van Sande J, Boeynaems JM: Biosynthesis and metabolism of 2-iodohexadecanal in cultured dog thyroid cells. J Biol Chem 271:23006-23014, 1996.
197.Ohayon R, Boeynaems J-M, Braekman J-C, Van den Bergen H, Gorin Y, Virion A: Inhibition of thyroid NADPH-oxidase by 2-iodohexadecanal in a cell-free system.Mol Cell Endocrinol 99:133-141, 1994.
198. Paneels V, Van den Bergen H, Jacoby C, Braekman J-C, Van Sande J, Dumont JE, Boeynaems J-M: Inhibition of H2O2 production by iodoaldehydes in cultured dog thyroid cells. Mol Cell Endocrinol 102:133-141, 1994.
199. Haeberli A, Millar FK, Wollman SH: Accumulation and localization of radiocalcium in the rat thyroid gland. Endocrinology 102:1511-1519, 1978.
200. Fonlupt P, Audebet C, Gire V, Bernier-Valentin F, Rousset B: Calcium is transported into the lumen of pig thyroid follicles by fluid phase basolateral to apical transcytosis. J Cell Physiol 171:43-51, 1997
201. Wollman SH, Ekholm R: Site of iodination in hyperplastic thyroid glands deduced from autoradiographs. Endocrinology 108:2082-2085, 1981.
202. Ekholm R: Iodination of thyroglobulin. An intracellular or extracellular process? Mol Cell Endocrinol 24:141-163, 1981.
203. Ofverholm T, Ericson LE: Intralumenal iodination of thyroglobulin. Endocrinology 114:827-835, 1984.
204. Gerber H, Studer H, von Grunigen C: Paradoxical effects of thyrotropin on diffusion of thyroglobulin in the colloid of rat follicles after long term thyroxine treatment. Endocrinology 116:303-310, 1985.
205. Herzog V, Berndorfer U, Saber Y: Isolation of insoluble secretory product from bovine thyroid: extracellular storage of thyroglobulin in covalently cross-linked form. J Cell Biol 118:1071-1083, 1992.
206. Berndorfer U, Wilms H, Herzog V: Multimerization of thyroglobulin (TG) during extracellular storage: isolation of highly cross-linked TG from human thyroids. J Clin Endocrinol Metab 81:1918-1926, 1996.
207. Baundry N, Lejeune P-J, Delom F, et al: Role of multimerized porcine thyroglobulin in iodine storage. Biochem Biophys Res Comm 242:292-296, 1998.
208. Saber-Lichtenberg Y, Brix K, Schmitz A, et al: Covalent cross-linking of secreted bovine thyroglobulin by transglutaminase. FASEB J 14:1005-1014, 2000.
209. Delom F, Mallet B,Carayon P, Lejeune PJ: Role of extracellular molecular chaperones in the folding of oxidized proteins.Refolding of colloid thyroglobulin by protein disulfide isomerase and immunoglobulin heavy chain-binding protein. J Biol Chem 276:21337-21342, 2001.
210. Ercson LE: Exocytosis and endocytosis in the thyroid cell. Mol Cell Endocrinol 22:1-24,1981.
211. Marino M, McCluskey RT: Role of thyroglobulin endocytic pathways in the control of thyroid hormone release. Am J Physiol Cell Physiol 279:C1295-C1306, 2000.
212. Pierce LR, Zurzolo C, Salvatore G, Edelhoch H: Coated vesicles from the thyroid gland: isolation, characterization and a search for a possible role in thyroglobulin transport. J Endocrinol Invest 8:303-312, 1985.
213. Bernier-Valentin, F, Kostrouch Z, Rabilloud R, et al: Coated vesicles from thyroid cells carry iodinated thyroglobulin molecules. J Biol Chem 265:17373-17380, 1990.
214. Bernier-Valentin F, Kostrouch Z, Rabilloud R, Rousset B: Analysis of the thyroglobulin internalization process using in vitro reconstituted thyroid follicles: evidence for a coated vesicle-dependent endocytic pathway. Endocrinology 129:2194-2201, 1991.
215. Kostrouch Z, Munari-Silem Y, Rajas F: Thyroglobulin internalized by thyrocytes passes through early and late endosomes. Endocrinology 129:2202-2211, 1991.
216. Kostrouch Z, Bernier-Valentin F, Munari-Silem Y, et al: Thyroglobulin molecules internalized by thyrocytes are sorted in early endosomes and partially recycled back to the follicular lumen. Endocrinology 132:2645-2653, 1993.
217. Miquelis R, Courageot J, Jacq A, Blanck O, Perrin C, Bastiani P: Intracellular routing of GlcNAc-bearing molecules in thyrocytes: selective recycling through the Golgi apparatus. J Cell Biol 123:1695-1706, 1993.
218. Herzog V: Transcytosis in thyroid follicle cells. J Cell Biol 97:607-617, 1983.
219. Romagnoli P, Herzog V: Transcytosis in thyroid follicle cells: Regulation and implications for thyroglobulin transport. Exp Cell Res 194:202-209, 1991.
220. Van den Hove MF, Couvreur .M, De Visscher M: A new mechanism for the reabsorption of thyroid iodoproteins : Selective fluid pinocytosis. Eur J Biochem 122:415-422, 1982.
221. Cortese F, Schneider AB,Salvatore G: Isopycnic centrifugation of thyroid iodoproteins : Selectivity of endocytosis. Eur J Biochem 68:121-129, 1976.
222. Consiglio E, Shifrin S, Yavin Z, Ambesi-Impiombato F, Rall JE, Salvatore G, Kohn LD: Thyroglobulin interactions with thyroid membranes. Relationship between receptor recognition of N-acetylglucosamine residues and the iodine content of thyroglobulin preparations. J Biol Chem 256:10592-10599, 1981.
223. Consiglio E, Salvatore G, Rall JE, Kohn LD: Thyroglobulin interactions with thyroid membranes. The existence of specific receptors and their potential role. J Biol Chem 254:5065-5076, 1979.
224. Montuori N, Pacifico F,Mellone S,Liguoro D, Di Jeso B, Formisano S, Gentile F, Consiglio E: The rat asialoglycoprotein receptor binds the amino-terminal domain of thyroglobulin. Biochem Biophys Res Commun 268:42-46, 2000.
225. Miquelis R, Alquier C, Monsigny M: The N-acetylglucosamine-specific receptor of the thyroid. Binding characteristics, partial characterization and potential role. J Biol Chem 262:15291-15298, 1987.
226. Mezgrhani H, Mziaut H, Courageot J, et al: Identification of the membrane receptor binding domain of thyroglobulin. J Biol Chem 272:23340-23346, 1997.
227. Zheng G, Marino M, Zhao J,McCluskey RT: Megalin (gp330): a putative endocytic receptor for thyroglobulin. Endocrinology 139:1462-1465, 1998.
228. Marino M, Zheng G, McCluskey RT: Megalin (gp330) is an endocytic receptor for thyroglobulin on cultured fisher rat thyroid cells. J Biol Chem 274:12898-12904, 1999.
229. Marino M, Friedlander JA, McCluskey RT, Andrews D: Identification of a heparin-binding region of rat thyroglobulin involved in megalin binding. J Biol Chem 274:30377-30386, 1999.
230. Marino M, Zheng G, Chivato L, Pinchera A, Brown D, Andrews D, McCluskey RT: Role og Megalin (gp330) in transcytosis of thyroglobulin by thyroid cells. A novel function in the control of thyroid hormone release. J Biol Chem 275:7125-7137, 2000.
231. Lisi S, Pinchera A, McCluskey RT, Willow TE, Refetoff S, Marcocci C, Vitti P, Menconi F, Grasso l, Luchetti F, Collins AB,Marino M: Preferential megalin-mediated transcytosis of low hormonogenic thyroglobulin: a control mechanism for thyroid hormone release. Proc Natl Acad Sci USA 100:14858-14863, 2003.
232. Neve P, Willems C, Dumont JE: Involvement of the microtubule-microfilament system in thyroid secretion. Exp Cell Res 63:457, 1970.
233. Ericson LE, Engstrom G: Quantitative electron microscopic studies on exocytosis and endocytosis in the thyroid follicle cell. Endocrinology 103:883-892, 1978.
234. Engstrom G, Ericson LE: Effect of graded doses of thyrotropin on exocytosis and early phase of endocytosis in the rat thyroid. Endocrinology 108:399-405, 1981.
235. Johanson V, Ofverholm T, Ericson LE: Forskolin-induced elevation of cyclic AMP does not cause exocytosis and endocytosis in rat thyroid follicle cells in vivo. Mol Cell Endocrinol 59:27-34, 1988.
236. Cochaux P, Van Sande J, Dumont JE: Inhibition of the cyclic AMP-adenylate cyclase system and of secretion by high concentrations of adenosine in the dog thyroid. Biochem Pharmacol 31:3763-3767, 1982.
237. Dunn AD, Dunn JT: Thyroglobulin degradation by thiol proteases: action of purified Cathepsin D. Endocrinology 11:280-289, 1982.
238. Dunn AD, Dunn JT: Thyroglobulin degradation by thiol proteases: action of thiol endopeptidases in vitro. Endocrinology 11:290-298, 1982.
239. . Dunn AD, Dunn JT: Cysteine proteinasee from human thyroid and their actions on thyroglobulin. Endocrinology 123:1089-1097, 1988.
240. Dunn AD, Crutchfield HE, Dunn JT: Thyroglobulin processing by thyroidal proteases. J Biol Chem 266:20198-20204, 1991.
241. Dunn AD, Muers HE, Dunn JT: The combined action of two thyroid proteases releases T4 from the dominant hormone-forming site of thyroglobulin. Endocrinology 137:3279-3285, 1996.
242. Nakagawa H,Ohtaki S: Partial purification and characterization of two thiol proteases from hog thyroid lysosomes. Endocrinology 115:33-40, 1984.
243. Yoshinari M, Taurog A: Lysosomal digestion of thyroglobulin. Role of cathepsin D and thiol proteases. Endocrinology 117:1621-1631, 1985.
244. Dunn AD, Crutchfield HE, Dunn JT: Proteolytic processing of thyroglobulin by extracts of thyroid lysosomes. Endocrinology 128:3073-3080, 1991.
245. Dunn AD, Myers HE, Dunn JT: The combined action of two thyroidal proteases releases T4 from the dominant hormone-forming site of thyroglobulin. Endocrinology 137: 279-3285, 1996.
246. Nakagawa H, Ohtaki S: Thyroxine release from thyroglobulin and its T4-containing peptide by thyroid thiol proteases. Endocrinology 116:1433-1439, 1985.
247. Alquier C, Guenin P, Munari-Silem Y,Audebet C, Rousset B: Isolation of pig thyroid lysosomes. Biochemical and morphological characterization. Biochem J 232:529-537, 1985.
248. Selmi S, Rousset B: Identification of two subpopulations of thyroid lysosomes: relation to the thyroglobulin proteolytic pathway. Biochem J 253:523-532, 1988.
249. Rousset B, Selmi S, Bornet H, Bourgeat P, Rabilloud R, Munari-silem Y: Thyroid hormone residues are released from thyroglobulin with limited alterations of the thyroglobulin structure. J Biol Chem 265:10950-10954, 1990.
250. Tepel C, Bromme D, Herzog V, Brix K: Cathepsin K in thyroid epithelial cells: sequence, localization and possible function in extracellular proteolysis of thyroglobulin. J Cell Sci 113:4487-4498, 2000.
251. Brix K, Linke M, Tepel C, Herzog V: Cysteine proteinases mediate extracellular prohormone processing in the thyroid. Biol Chem 382:717-725, 2001.
252. Linke M, Herzog V, Brix K: Trafficking of lysosomal cathepsin B-green fluorescent protein to the surface of thyroid epithelial cells involves the endosomal/lysosomal compartment. J Cell Sci 115:4877-4889, 2002.
253. Friedrichs B, Tepel C, Reinheckel T, Deussing J, von Figura K, Herzog V, Peters C, Saftig P, Brix K: Thyroid functions of mouse cathepsins B,K,and L. J Clin Invest 111:1733-1745, 2003.
254. Rousset B, Mornex R: The thyroid hormone secretary pathway- Current dogmas and alternative hypotheses. Mol Cell Endocrinol 78:C89-C93, 1991.
255. Tietze F, Kohn LD, Kohn AD, Bernardini I, Andersson HC, Adamson MD, Harper GS, Gahl WA: Carrier-mediated transport of monoiodotyrosine out of thyroid cell lysosomes. J Biol Chem 264:4762-4765, 1989.
256. Andersson Hc,Kohn LD, Bernardini I, Blom HJ, Tietze F,Gahl WA: Characterization of lysosomal monoiodotyrosine transport in rat thyroid cells. Evidence for transport by system H. J Biol Chem 265:10950-10954, 1990.
257. Toyoda N, Nishikawa M, Mori Y, Yoshimura M, Masaki H, Gondou A, Yonemoto T, Inada M. Identification of a 27-kilodalton protein with the properties of Type I Iodothyronine 5'-deiodinase in human thyroid gland. J Clin Endocrinol Metab 74:533-538, 1992.
258. Toyoda N, Nishikawa M, Mori Y, Gondou A, Ogawa Y, Yonemoto T, Yoshimura M, Masaki H, Inada M. Thyrotropin and triiodothyronine regulate iodothyronine 5'-deiodinase messenger ribonucleic acid levels in FRTL-5 rat thyroid cells. Endocrinology 131:389-394, 1992.
259. Fisher DA, Oddie TH, Thompson CS: Thyroidal thyronine and non-thyronine iodine secretion in euthyroid subjects. J Clin Endocrinol Metab 33:647, 1971.
260. Rosenberg IN, Goswami A: Purification and characterization of a flavoprotein from bovine thyroid with iodotyrosine deiodinase activity. J Biol Chem 254:12318-12385, 1979.
261. Medeiros-Neto G, Stanbury JB: The iodotyrosine deiodinase defect. In: Inherited Disorders of the Thyroid System. CRC Press, 1994, pp 139-159.
262. Ohtaki S, Moriya S, Suzuki H, Horiuchi Y: Nonhormonal iodine escape from the normal and abnormal thyroid gland. J Clin Endocrinol Metab 27:728, 1967.
263. Kubota K, Uchimura H, Mitsuhashi T, Chiu SC, Kuzuya N, Nagataki S: Effects of intrathyroidal metabolism of thyroxine on thyroid hormone secretion: increased degradation of thyroxine in mouse thyroids stimulated chronically with thyrotrophin. Acta Endocrinol 105:57, 1984.
264. Eggo MC, Burrow GN: Integrated regulation of growth and of function. Control of the Thyroid Gland. Regulation of Its Normal Function and Growth. Eds: Ekholm R, Kohn LD, Wollman SH. Plenum Press, New York, 1989, pp 327-339.
265. Hjort T: Determination of serum-thyroglobulin by a haemagglutination-inhibition test. Lancet 1:1262-1264, 1961.
266. Roitt IM, Torrigiani G: Identification and estimation ofundegraded thyroglobulin in human serum. Endocrinology 81:421-429, 1967.
267. Van Herle AJ, Uller RP: Elevated serum thyroglobulin; a marker ofmetastases in differential thyroid carcinomas. J Clin Invest 56:272-277, 1975.
268. Schneider AB, Ikekubo K, Kuma K: Iodine content of serum thyroglobulin in normal individuals and patients withthyroid tumors. J Clin Invest 57:1251-1256, 1983.
269. Druetta L, Croizet K, Bornet H, Rousset B: Analyses of the molecular forms of serum thyroglobulin from patients with Graves’ disease, subacute thyroiditis or differentiated thyroid cancer by velocity sedimentation on sucrose gradient and Western blot. Eur J Endocrinol 139:498-507, 1998.
270. Druetta L, Bornet H, Sassolas G, Rousset B: Identification of thyroid hormone residues on serum thyroglobulin: a clue to the source of circulating thyroglobulin in thyroid diseases. Eur J Endocrinol 140:457-467, 1999.
271. Spencer CA: Serum thyroglobulin measurements: clinical utility and technical limitations in the management of patients with differentiated thyroid carcinomas. Endocr Pract 6:481-484, 2000.
272. Ladenson PW, Braverman LE, Mazzaferri EL, Brucker-Davis F, Cooper DS, Garber JR, Wondisford FE, Davies TF, DeGroot LJ, Daniels GH, Ross DS, Weintraub BD: Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma. N Engl J Med 337:888-896, 1997.
273. Schlumberger M, Ricard M, Pacini F: Clinical use of recombinant human TSH in thyroid cancer patients. Eur J Endocrinol 143:557-567, 2000.
274. McDougall IR, Weigel RJ: Recombinant human thyrotropin in the management of thyroid cancer. Curr Opin Oncol 13:39-43, 2001.
275. Robbins RJ,Tuttle RM, Sharaf RN, Larson SM, Robbins HK, Ghossein RA, Smith A, Drucker WD: Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinomas. J Clin Endocr Metab 86:619-625, 2001.
276. Wartofsky L: rhTSH-stimulated Thyroglobulin Study Group: Management of low-risk well-differentiated thyroid cancer based only on thyroglobulin measurement after recombinant human thyrotropin. Thyroid 12:583-590, 2002.
277. Mazzaferri EL,Robbins RJ, Spencer CA, Braverman LE, Pacini F, Wartofsky L, Haugen BR, Sherman SI, Cooper DS, Braunstein GD, Davies TF, Arafah BM, Ladenson PW, Pinchera A: A concensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinomas. J Clin Endocr Metab 88:1433-1441, 2003.